109 followers
RT @DiabetologiaJnl: In vivo studies with rodents suggest that combined use of PPARγ agonist, SMAD3 inhibitor and adrenergic receptor agoni…
17,800 followers
In vivo studies with rodents suggest that combined use of PPARγ agonist, SMAD3 inhibitor and adrenergic receptor agonist induces synergistic induction of UCP1 in s.c. adipose and ameliorates metabolic dysfunction #Obesity #T2D #Adipocytes #Browning https:/
945 followers
RT @DanielJDrucker: “PPARγ, SMAD and the adrenergic receptor signalling pathway synergistically induces brown adipogenesis and may serve as…
372 followers
RT @DanielJDrucker: “PPARγ, SMAD and the adrenergic receptor signalling pathway synergistically induces brown adipogenesis and may serve as…
1,855 followers
RT @DanielJDrucker: “PPARγ, SMAD and the adrenergic receptor signalling pathway synergistically induces brown adipogenesis and may serve as…
28,115 followers
“PPARγ, SMAD and the adrenergic receptor signalling pathway synergistically induces brown adipogenesis and may serve as an effective strategy to treat obesity and related diseases, including type 2 diabetes” Humans? Not likely... @DiabetologiaJnl https://